Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


? GENERIC ENTERCAVIR BY RANBAXY
Jul 22, 2010

I write to confirm if you are aware of the approval given to ranbaxy by an indian court. I want to know if it is true and when most developing countries can have access to the drug. I have been on the original entercavir for 5 months and must confess it draining my pocket.I have no end time in site even though my DNA is undetectable.Sometimes am tempted to stop but kept struggling on. Pls is there no recent drug improvement that will give specific treatment time or manufacturers are more concern about their gain and less with the pain we go through Thanks Dennis

Response from Dr. McGovern

All I know is from what has been noted on the internet back in March. I am sorry I can't be of more assistance.



Previous
confuse with liver result
Next
hepatitis serelogy

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement